Synthesis of polyamidoamine dendrimers having poly (ethylene glycol) grafts and their ability to encapsulate anticancer drugs
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Polyamidoamine dendrimers having poly(ethylene glycol) grafts were designed as a novel drug carrier which possesses an interior for the encapsulation of drugs and a biocompatible surface. Poly(ethylene glycol) monomethyl ether with the average molecular weight of 550 or 2000 was combined to essentially every chain end of the dendrimer of the third or fourth generation via urethane bond. The poly(ethylene glycol)-attached dendrimers encapsulating anticancer drugs, adriamycin and methotrexate, were prepared by extraction with chloroform from mixtures of the poly(ethylene glycol)-attached dendrimers and varying amounts of the drugs. Their ability to encapsulate these drugs increased with increasing dendrimer generation and chain length of poly(ethylene glycol) grafts. Among the poly(ethylene glycol)-attached dendrimers prepared, the highest ability was achieved by the dendrimer of the fourth generation having the poly(ethylene glycol) grafts with the average molecular weight of 2000, which could retain 6.5 adriamycin molecules or 26 methotrexate molecules/dendrimer molecule. The methotrexate-loaded poly(ethylene glycol)-attached dendrimers released the drug slowly in an aqueous solution of low ionic strength. However, in isotonic solutions, methotrexate and adriamycin were readily released from the poly(ethylene glycol)-attached dendrimers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dendrimers are commonly used as building blocks to prepare unimolecular micelles, because of their well-defined globular architecture, high-branching, and controlled surface functionality [156, 157].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [157]
Citations
Cites
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Hawker, C. J., & Frechet, J. M. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00177a027 · Cited by 2,413
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Self-citationMalik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Sterically stabilized liposomes
Woodle, M. C., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 954
Integration of Layered Redox Proteins and Conductive Supports for Bioelectronic Applications
Willner, I., & Katz, E. Y. (2000) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(20000403)39:7<1285::aid-anie1285>3.0.co;2-f · Cited by 949
Dendritic Molecules: Concepts, Syntheses, Perspectives
Newkome, G. R., Moorefield, C. N., & Vögtle, F. (1996) · Wiley eBooks · doi:10.1002/9783527614875 · Cited by 806
Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers
Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199601)30:1<53::aid-jbm8>3.0.co;2-q · Cited by 589
Starburst dendrimers. 5. Molecular shape control
Naylor, A. M., Goddard, W. A., Kiefer, G. E., & Tomalia, D. A. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00188a079 · Cited by 513
The "Stealth" Liposome: A Prototypical Biomaterial
Lasic, D. D., & Needham, D. (1995) · Chemical Reviews · doi:10.1021/cr00040a001 · Cited by 416
Research works printed but not linked: 23
- Fréchet J. M. J., 1994, Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science 263, 1710−1715
- Tomalia D. A., 1985, Polym. J. 17, 117−132
- Hawker C. J., 1992, J. Am. Chem. Soc., 4
- Jansen J. F. G. A., 1994, Encapsulation of guest molecules into a dendritic box. Science 266, 1226−1229
- Newkome G. R., 1991, Engl. 30, 1178−1180.
- Liu M., 1999, Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 2, 393−401
- Zhuo R. X., 1999, J. Controlled Release, 57
- Kono K., 1999, Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chem. 10, 1115−1121
- Newkome G. R., 1991, Engl. 30, 1176−1178.
- Hawker C. J., 1993, J. Chem. Soc., Perkin Trans., 1
- Twyman L. J., 1999, Tetrahedron Lett., 40
- Jansen J. F. G. A., 1995, J. Am. Chem. Soc., 117
- Abuchowski A., 1977, J. Biol. Chem., 252
- Abuchowski A., 1977, J. Biol. Chem., 252
- Yokoyama M., 1991, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51, 3229−3236
- Blume B., 1990, Biochim. Biophys. Acta, 1029, 97
- Liu M., 2000, J. Controlled Release, 65
- Liu M., 1999, Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers. J. Polym. Sci. Part A: Polym
- Pan Y., 1999, Dendrimers with both hydrophilic and hydrophobic chains at every end. Macromolecules 32, 5468−5470
- Baars M. W., 2000, The localization of guests in water-soluble oligoethyleneoxy-modified poly(propylene imine) dendrimers
- Ritscher V. T. A., 1959, Makromol. Chem., 30, 80
- Kataoka K., 2000, J. Controlled Release 64, 143−153
- Abbreviations PAMAM, 2000, polyamidoamine
Cited by
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
“, indomethacin, doxorubicin, methotrexate and 10-hydroxycamptothecin”
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Nanostructured materials for applications in drug delivery and tissue engineering
Goldberg, M., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,054
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“Dendrimers are commonly used as building blocks to prepare unimolecular micelles, because of their well-defined globular architecture, high-branching, and controlled surface functionality [156,157].”
BackgroundStiriba, S.-E., Frey, H., & Haag, R. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1329::aid-anie1329>3.0.co;2-p · Cited by 672
Biomedical applications of dendrimers: a tutorial
Mintzer, M. A., & Grinstaff, M. W. (2011) · Chem. Soc. Rev. · doi:10.1039/b901839p · Cited by 671
Dendrimers as Carriers for Delivery of Chemotherapeutic Agents
Medina, S. H., & El-Sayed, M. E. H. (2009) · Chemical Reviews · doi:10.1021/cr900174j · Cited by 669
Polymer Architecture and Drug Delivery
Qiu, L. Y., & Bae, Y. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9046-2 · Cited by 604
“When using a dendrimer as the drug-loaded core, it was also demonstrated that micelles with a larger dendrimer core had higher encapsulation ability than those with smaller cores (159,160).”
MethodPATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
“Research efforts on drug encapsulation in dendrimers led to the synthesis of polyethylene glycol (PEG) functionalized dendrimers to impart aqueous solubility, biocompatibility, and increased drug loading with greater size of the dendrimer [24,25].”
BackgroundDendritic polymer macromolecular carriers for drug delivery
Patri, A. K., Majoros, I. J., & Baker, J. R. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00347-2 · Cited by 595
Dendrimers in biomedical applications—reflections on the field
Svenson, S., & Tomalia, D. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.030 · Cited by 593
Supramolecular Drug‐Delivery Systems Based on Polymeric Core–Shell Architectures
Haag, R. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200301694 · Cited by 591
DEMANUELE, A., & ATTWOOD, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.012 · Cited by 571
Dendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496
Advanced functional materials based on polyhedral oligomeric silsesquioxane (POSS)
Tanaka, K., & Chujo, Y. (2012) · J. Mater. Chem. · doi:10.1039/c1jm14231c · Cited by 489
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Abedi-Gaballu, F., Dehghan, G., Ghaffari, M., Yekta, R., Abbaspour-Ravasjani, S., Baradaran, B., Ezzati Nazhad Dolatabadi, J., & Hamblin, M. R. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2018.05.002 · Cited by 487
“It was concluded that the high MTX encapsulation efficacy was related to the electrostatic interactions among negative charges of MTX and positive charges of the PAMAM-G4 dendrimer [48].”
BackgroundDendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Nano-oncology: drug delivery, imaging, and sensing
Portney, N. G., & Ozkan, M. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-0247-7 · Cited by 456
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Core cross-linked star polymers via controlled radical polymerisation
Blencowe, A., Tan, J. F., Goh, T. K., & Qiao, G. G. (2009) · Polymer · doi:10.1016/j.polymer.2008.09.049 · Cited by 433
Advanced drug delivery systems: Nanotechnology of health design A review
Safari, J., & Zarnegar, Z. (2014) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2012.12.009 · Cited by 429
“…or other bioactive agents from dendrimers leads to reduced toxicity, increased bioavailability and a simplified dosing schedule (Konda et al., 2002; Kojima et al., 2000) Prolonged residence time of the drug in the blood and protection of the bioactives from their environment with increased…”
BackgroundDrug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
Kolhe, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00225-4 · Cited by 412
Chen, H.-T., Neerman, M. F., Parrish, A. R., & Simanek, E. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048548j · Cited by 411
Luong, D., Kesharwani, P., Deshmukh, R., Mohd Amin, M. C. I., Gupta, U., Greish, K., & Iyer, A. K. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.015 · Cited by 408
Dendrimers: a new class of nanoscopic containers and delivery devices
Aulenta, F., Hayes, W., & Rannard, S. (2003) · European Polymer Journal · doi:10.1016/s0014-3057(03)00100-9 · Cited by 400
Lee, H., de Vries, A. H., Marrink, S.-J., & Pastor, R. W. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9058966 · Cited by 398
Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement
Gupta, U., Agashe, H. B., Asthana, A., & Jain, N. K. (2006) · Biomacromolecules · doi:10.1021/bm050802s · Cited by 375
Newkome, G. R., & Shreiner, C. D. (2008) · Polymer · doi:10.1016/j.polymer.2007.10.021 · Cited by 368
“5 molecules of the former and 26 of the latter [1186].”
BackgroundPeptide dendrimers: applications and synthesis
Sadler, K., & Tam, J. P. (2002) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00061-7 · Cited by 365
“PAMAM dendrimers with poly ethylene glycol grafts prior to delivery in order to increase effiŽ .cacy Kojima et al., 2000 .”
Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 337
Mignani, S., El Kazzouli, S., Bousmina, M., & Majoral, J.-P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.001 · Cited by 335
Singh, P., Gupta, U., Asthana, A., & Jain, N. K. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800125u · Cited by 329
Amir, R. J., Pessah, N., Shamis, M., & Shabat, D. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351962 · Cited by 325
Advances in PEGylation of important biotech molecules: delivery aspects
Ryan, S. M., Mantovani, G., Wang, X., Haddleton, D. M., & Brayden, D. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.371 · Cited by 323
“The effect of PEG chain length on dendrimer-mediated solubility was also studied [87] .”
BackgroundWang, F., Bronich, T. K., Kabanov, A. V., Rauh, R. D., & Roovers, J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049784m · Cited by 317
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
Nanotechnological carriers for cancer chemotherapy: The state of the art
Estanqueiro, M., Amaral, M. H., Conceição, J., & Sousa Lobo, J. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.12.041 · Cited by 298
Rowe, M. D., Thamm, D. H., Kraft, S. L., & Boyes, S. G. (2009) · Biomacromolecules · doi:10.1021/bm900043e · Cited by 286
Targeting and Inhibition of Cell Growth by an Engineered Dendritic Nanodevice
Thomas, T. P., Majoros, I. J., Kotlyar, A., Kukowska-Latallo, J. F., Bielinska, A., Myc, A., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040187v · Cited by 269
Nemanashi, M., & Meijboom, R. (2013) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.09.012 · Cited by 266
Iodinated blood pool contrast media for preclinical X-ray imaging applications – A review
Hallouard, F., Anton, N., Choquet, P., Constantinesco, A., & Vandamme, T. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.066 · Cited by 265
“The encapsulation rates and release kinetics are respectively improved and slowed down in PEG or chondroitin sulfate A (CSA) coated dendrimers as opposed to non-coated dendrimers [206,214,217].”
BackgroundDendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges
Wu, L.-P., Ficker, M., Christensen, J. B., Trohopoulos, P. N., & Moghimi, S. M. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00031 · Cited by 239
Dhanikula, R. S., Argaw, A., Bouchard, J.-F., & Hildgen, P. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700086j · Cited by 246
Patri, A. K., Myc, A., Beals, J., Thomas, T. P., Bander, N. H., & Baker, J. R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499127 · Cited by 249
Star-shaped polymers having PEO arms
Lapienis, G. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.04.006 · Cited by 240
Agrawal, P., Gupta, U., & Jain, N. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.004 · Cited by 241
Dendrimeric micelles for controlled drug release and targeted delivery
Ambade, A. V., Savariar, E. N., & Thayumanavan, S. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050020d · Cited by 245
Development of macromolecular prodrug for rheumatoid arthritis
Yuan, F., Quan, L.-D., Cui, L., Goldring, S. R., & Wang, D. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.006 · Cited by 239
Nanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
“Multiple entities including both hydrophobic and hydrophilic molecules can be conjugated to dendrimers due to their exclusive branching point [103, 117–119].”
BackgroundDendrimer-encapsulated metal nanoparticles and their applications to catalysis
Niu, Y., & Crooks, R. M. (2003) · Comptes Rendus. Chimie · doi:10.1016/j.crci.2003.08.001 · Cited by 232
Applications of Dendrimers in Drug Delivery Agents, Diagnosis, Therapy, and Detection
Noriega-Luna, B., Godínez, L. A., Rodríguez, F. J., Rodríguez, A., Zaldívar-Lelo de Larrea, G., Sosa-Ferreyra, C. F., Mercado-Curiel, R. F., Manríquez, J., & Bustos, E. (2014) · Journal of Nanomaterials · doi:10.1155/2014/507273 · Cited by 224
Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules
Choudhary, S., Gupta, L., Rani, S., Dave, K., & Gupta, U. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00261 · Cited by 221
“…after exposure to biological fluids the drugdendrimer structure can fail to control the release of the drug from the dendrimer pockets/cavities (Kojima et al., 2000; Liu, 2008; Kesharwani et al., 2014) due to insufficient interactive forces between the drug and the dendrimer molecules…”
BackgroundInfluentialComplexes of Dendrimers with Bovine Serum Albumin
Mandeville, J. S., & Tajmir-Riahi, H. A. (2010) · Biomacromolecules · doi:10.1021/bm9011979 · Cited by 223
Dendrimers Bind Human Serum Albumin
Froehlich, E., Mandeville, J. S., Jennings, C. J., Sedaghat-Herati, R., & Tajmir-Riahi, H. A. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9011119 · Cited by 221
Bimetallic dendrimer-encapsulated nanoparticles as catalysts: a review of the research advances
Peng, X., Pan, Q., & Rempel, G. L. (2008) · Chemical Society Reviews · doi:10.1039/b716441f · Cited by 224
Dendrimers in combination with natural products and analogues as anti-cancer agents
Mignani, S., Rodrigues, J., Tomas, H., Zablocka, M., Shi, X., Caminade, A.-M., & Majoral, J.-P. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00550d · Cited by 219
Interactions between PAMAM dendrimers and bovine serum albumin
Klajnert, B., Stanisławska, L., Bryszewska, M., & Pałecz, B. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00117-1 · Cited by 221
DEVARAKONDA, B., HILL, R., & DEVILLIERS, M. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.006 · Cited by 215
Can Controversial Nanotechnology Promise Drug Delivery?
Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R. (2013) · Chemical Reviews · doi:10.1021/cr300047q · Cited by 210
Li, X., Takashima, M., Yuba, E., Harada, A., & Kono, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.043 · Cited by 212
Self-citationDendrimer‐based nanocarriers: a versatile platform for drug delivery
Hsu, H., Bugno, J., Lee, S., & Hong, S. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1409 · Cited by 204
“Although better core enclosure enhances the drug encapsulation, an uncontrolled burst release of encapsulated molecules in physiological solutions seems inevitable.(56,57) For example, it has been shown in PBS that more than 70% of MTX releases from the G5 PAMAM–MTX inclusion complex after a 2.”
BackgroundBioinspired application of dendrimers: From bio-mimicry to biomedical applications
Jang, W.-D., Kamruzzaman Selim, K. M., Lee, C.-H., & Kang, I.-K. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.08.003 · Cited by 209
Ornelas, C., Aranzaes, J. R., Salmon, L., & Astruc, D. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200701410 · Cited by 204
Cheng, Y., Qu, H., Ma, M., Xu, Z., Xu, P., Fang, Y., & Xu, T. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.035 · Cited by 206
Giant Dendritic Molecular Electrochrome Batteries with Ferrocenyl and Pentamethylferrocenyl Termini
Ornelas, C., Ruiz, J., Belin, C., & Astruc, D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8062343 · Cited by 188
In Vitro Targeting of Synthesized Antibody-Conjugated Dendrimer Nanoparticles
Thomas, T. P., Patri, A. K., Myc, A., Myaing, M. T., Ye, J. Y., Norris, T. B., & Baker, J. R. (2004) · Biomacromolecules · doi:10.1021/bm049704h · Cited by 193
Drug Delivery Nanoparticles in Skin Cancers
Dianzani, C., Zara, G. P., Maina, G., Pettazzoni, P., Pizzimenti, S., Rossi, F., Gigliotti, C. L., Ciamporcero, E. S., Daga, M., & Barrera, G. (2014) · BioMed Research International · doi:10.1155/2014/895986 · Cited by 184
Kono, K., Kojima, C., Hayashi, N., Nishisaka, E., Kiura, K., Watarai, S., & Harada, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.017 · Cited by 192
“For an earlier study, we developed polyamidoamine (PAMAM) dendrimers with PEG grafts at all chain ends, in which the dendrimer surface was covered efficiently with biocompatible PEG chains [13,24,25].”
BackgroundMethodSelf-citationSynthesis and Applications of Perfunctionalized Boron Clusters
Axtell, J. C., Saleh, L. M. A., Qian, E. A., Wixtrom, A. I., & Spokoyny, A. M. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b02912 · Cited by 183
Ma, M., Cheng, Y., Xu, Z., Xu, P., Qu, H., Fang, Y., Xu, T., & Wen, L. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.07.015 · Cited by 190
Remote and local control of stimuli responsive materials for therapeutic applications
Chan, A., Orme, R. P., Fricker, R. A., & Roach, P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.007 · Cited by 190
Wang, Y., Guo, R., Cao, X., Shen, M., & Shi, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.060 · Cited by 189
Agashe, H. B., Dutta, T., Garg, M., & Jain, N. K. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.11.0010 · Cited by 185
“…make the system more suitable for the proposed application, enhancing the peripheral congestion to improve container properties and attachment of targeting groups to the periphery (Kojima et al 2000; Liu et al 2000; Sideratou et al 2000; Quintana et al 2002; Bhadra et al 2003; Bhadra et al 2005).”
BackgroundChauhan, A. S., Diwan, P. V., Jain, N. K., & Tomalia, D. A. (2009) · Biomacromolecules · doi:10.1021/bm9000298 · Cited by 182
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
Cheng, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2774 · Cited by 184
“The attractive features of dendrimers, when compared with traditional linear polymers, make them interesting candidates for the development of novel delivery systems for NSAIDs (26).”
BackgroundDendrimers for pharmaceutical and biomedical applications
Yang, H., & Kao, W. J. (2006) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856206774879171 · Cited by 183
Chandrasekar, D., Sistla, R., Ahmad, F. J., Khar, R. K., & Diwan, P. V. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.07.046 · Cited by 183
“Dendrimers conjugates have been used for delivering drugs [8,9], DNA [10,11], radionucleides [12], MRI contrast agents [13] and boron for neutron capture therapy [14].”
BackgroundYang, H., Morris, J. J., & Lopina, S. T. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2003.12.023 · Cited by 184
Han, L., Huang, R., Liu, S., Huang, S., & Jiang, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100185f · Cited by 182
Niu, Y., Sun, L., & Crooks, R. M. (2003) · Macromolecules · doi:10.1021/ma034276d · Cited by 182
Wang, Y., & Grayson, S. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.011 · Cited by 179
Loading of polymer nanocarriers: Factors, mechanisms and applications
Kowalczuk, A., Trzcinska, R., Trzebicka, B., Müller, A. H. E., Dworak, A., & Tsvetanov, C. B. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.10.004 · Cited by 176
Nanodelivery Strategies in Cancer Chemotherapy: Biological Rationale and Pharmaceutical Perspectives
Mattheolabakis, G., Rigas, B., & Constantinides, P. P. (2012) · Nanomedicine · doi:10.2217/nnm.12.128 · Cited by 177
Dendrimer-based nanodevices for targeted drug delivery applications
Zhu, J., & Shi, X. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20724b · Cited by 175
Yiyun, C., & Tongwen, X. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.06.010 · Cited by 167
Boyd, B. J., Kaminskas, L. M., Karellas, P., Krippner, G., Lessene, R., & Porter, C. J. H. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060032e · Cited by 167
Taratula, O., Schumann, C., Naleway, M. A., Pang, A. J., Chon, K. J., & Taratula, O. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400397t · Cited by 165
PEG-conjugated PAMAM Dendrimers Mediate Efficient Intramuscular Gene Expression
Qi, R., Gao, Y., Tang, Y., He, R.-R., Liu, T.-L., He, Y., Sun, S., Li, B.-Y., Li, Y.-B., & Liu, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9116-1 · Cited by 168
Biologically Optimized Nanosized Molecules and Particles: More than Just Size
Longmire, M. R., Ogawa, M., Choyke, P. L., & Kobayashi, H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200111p · Cited by 167
Kolhe, P., Khandare, J., Pillai, O., Kannan, S., Lieh-Lai, M., & Kannan, R. M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.06.007 · Cited by 165
“In the past, various strategies have been devised to modify dendrimers with drug molecules, genetic materials, targeting agents, dyes and imaging agents, either by encapsulation or conjugation [4–14].”
BackgroundKim, Y., Klutz, A. M., & Jacobson, K. A. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700483s · Cited by 168
Bunker, A., & Róg, T. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.604770 · Cited by 174
Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
Srinivasan, M., Rajabi, M., & Mousa, S. (2015) · Nanomaterials · doi:10.3390/nano5041690 · Cited by 158
“Dendritic molecules, such as polyamidoamine (PAMAM), poly(propylene imine) polyamide, polyglycerol (PG) and triazine, are synthesized by assembling monomeric subunits to form uniform tree-like structures that allow for encapsulation of the drug payload in the internal star structure, while the branches can be complexe…”
BackgroundChauhan, A. S., Jain, N. K., Diwan, P. V., & Khopade, A. J. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010655 · Cited by 158
“…encapsulation or by complexation with surface functional groups (Kono et al., 1999; Khopade et al., 1999), (ii) drug encapsulation in pegylated dendrimer (Kojima et al., 2000), and (iii) dendrimer–liposome interaction and its affect on drug encapsulation and release (Khopade et al., 2002).”
Background
Metadata
- Authors
- Kojima, C., Kono, K., Maruyama, K., & Takagishi, T.
- Affiliations
- Osaka Prefecture University (JP)
- Corresponding author
- Kono, Kenji
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-11-01
- Volume
- 11
- Issue
- 6
- Pages
- 910-917
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2022549879
- Cited by
- 663
- References
- 17
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 20 · 2021: 12 · 2020: 23 · 2019: 19 · 2018: 16 · 2017: 26 · 2016: 31 · 2015: 37 · 2014: 40 · 2013: 45 · 2012: 47
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bioconjugate Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Shorai Foundation for Science and Technology
- Topics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- PAMAM dendrimers, drug encapsulation, drug carriers, doxorubicin, methotrexate, anticancer agents, dendrimer generation, drug loading, controlled drug release, chloroform extraction
- MeSH terms
- Antineoplastic Agents, Doxorubicin, Drug Carriers, Drug Compounding, Methotrexate, Magnetic Resonance Spectroscopy, Polyamines, Polyethylene Glycols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.